These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 6755284)

  • 1. Gastrointestinal toxicity of cis-diamminedichloroplatinum (II).
    Vermorken JB; Pinedo HM
    Neth J Med; 1982; 25(8):275-9. PubMed ID: 6755284
    [No Abstract]   [Full Text] [Related]  

  • 2. Gastrointestinal toxicity of cis-diamminedichloroplatinum (II).
    Vermorken JB; Pinedo HM
    Neth J Med; 1982; 25(8):270-4. PubMed ID: 6890632
    [No Abstract]   [Full Text] [Related]  

  • 3. A phase I study of intracarotid artery infusion of cis-Diamminedichloroplatinum(II) in patients with recurrent malignant intracerebral tumors.
    Stewart DJ; Wallace S; Feun L; Leavens M; Young SE; Handel S; Mavligit G; Benjamin RS
    Cancer Res; 1982 May; 42(5):2059-62. PubMed ID: 7199971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aprepitant (EMEND): the role of substance P in nausea and vomiting.
    Prommer E
    J Pain Palliat Care Pharmacother; 2005; 19(3):31-9. PubMed ID: 16219609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
    Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P
    J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of ramosetron plus dexamethasone in the prevention of cisplatin-induced nausea and vomiting.
    Voravud N; Sriuranpong V
    J Med Assoc Thai; 2005 Dec; 88(12):1790-6. PubMed ID: 16518975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomized controlled trial.
    Mantovani G; Macciò A; Bianchi A; Curreli L; Ghiani M; Proto E; Santona MC
    Cancer; 1996 Mar; 77(5):941-8. PubMed ID: 8608488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of hexamethylmelamine, cis-diamminedichloroplatinum, and mitomycin-C in advanced breast cancer. A pilot study of the Southeastern Cancer Study Group.
    Lawson D; Moore M; Smalley R
    Cancer Clin Trials; 1980; 3(4):293-6. PubMed ID: 6775826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of the time of administration on cis-platinum induced nausea and vomiting.
    Moore JM
    Oncol Nurs Forum; 1982; 9(3):26-32. PubMed ID: 6921790
    [No Abstract]   [Full Text] [Related]  

  • 10. Dexamethasone as an antiemetic in patients treated with cisplatin.
    Aapro MS; Alberts DS
    N Engl J Med; 1981 Aug; 305(9):520. PubMed ID: 7195983
    [No Abstract]   [Full Text] [Related]  

  • 11. [A randomized trial of Zudan in the prophylaxis of nausea and vomiting induced by cisplatin].
    Huang J; Wang Z; Zhou L
    Zhonghua Zhong Liu Za Zhi; 1998 Mar; 20(2):153-4. PubMed ID: 10920971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of 2-mg granisetron tablet for nausea and vomiting induced by anticancer drugs including cisplatin].
    Yoshiya N; Kodama S; Aoki Y; Takahashi T; Honma S; Endo M; Tokunaga A; Takeuchi Y; Hanaoka J; Maruhashi T; Oshima T; Tanaka K; Furue H
    Gan To Kagaku Ryoho; 1997 Jul; 24(9):1141-7. PubMed ID: 9239168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of effects between single vs five-day injection of granisetron for combination chemotherapy with cisplatin and 5-fluorouracil for head and neck cancer].
    Fujii M; Ohno Y; Tokumaru Y; Imanishi Y; Kanke M; Kanzaki J
    Gan To Kagaku Ryoho; 1997 Jul; 24(9):1095-101. PubMed ID: 9239162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phase-II-study with cis-diamminedichloroplatinum (II) in the treatment of advanced malignant lymphomas].
    Cavalli F; Jungi WF; Sonntag RW; Nissen NI; Holland JH
    Schweiz Med Wochenschr; 1980 Jul; 110(27-28):1067-70. PubMed ID: 7191577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of 2 mg granisetron tablet for nausea and vomiting induced by anticancer drugs including cisplatin].
    Takada M; Furuse K; Fukuoka M; Kawahara M; Negoro S; Kusunoki Y; Ogawara M; Furue H
    Gan To Kagaku Ryoho; 1997 Jun; 24(8):987-94. PubMed ID: 9212809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved control of high-dose-cisplatin-induced acute emesis with the addition of prochlorperazine to granisetron/dexamethasone.
    Hesketh PJ; Gandara DR; Hesketh AM; Edelman M; Webber LM; McManus M; Hainsworth JD
    Cancer J Sci Am; 1997; 3(3):180-3. PubMed ID: 9161784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of the oral NK1 antagonist aprepitant to standard antiemetics provides protection against nausea and vomiting during multiple cycles of cisplatin-based chemotherapy.
    de Wit R; Herrstedt J; Rapoport B; Carides AD; Carides G; Elmer M; Schmidt C; Evans JK; Horgan KJ
    J Clin Oncol; 2003 Nov; 21(22):4105-11. PubMed ID: 14559891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The prevention of CDDP-induced emesis with granisetron].
    Fukunaka N; Sagae S; Kitajima Y; Ishioka S; Sato K; Itoh E; Kudo R
    Gan To Kagaku Ryoho; 1993 Jun; 20(8):1101-5. PubMed ID: 8390228
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of cisplatin-induced delayed emesis: still unsatisfactory. Italian Group for Antiemetic Research.
    Support Care Cancer; 2000 May; 8(3):229-32. PubMed ID: 10789965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of dexamethasone in the decrease of chemotherapy-induced nausea and vomiting.
    Sarcev T; Secen N; Povazan Dj; Sabo A; Popovic J; Bursac D; Kakas M; Zaric B; Milovancev A
    J BUON; 2007; 12(2):245-52. PubMed ID: 17600880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.